Lorbrexen 100 mg (Lorlatinib) | Online International Pharmacy Lorbrexen 100 mg (Lorlatinib) is a targeted therapy for ALK-positive non-small cell lung cancer, inhibiting tumor growth and spread.

Lorbrexen 100 mg (Lorlatinib) is an oral targeted therapy used to treat ALK-positive or ROS1-positive non-small cell lung cancer, effectively these kinases to slow tumor growth and prevent cancer progression.
#Lorbrexen100mg #Lorlatinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/lorb...

Laronib 100 mg (Larotrectinib) | Online International Pharmacy Laronib 100 mg (Larotrectinib) is a targeted cancer therapy for treating solid tumors with NTRK gene fusions, regardless of location.

Laronib 100 mg (Larotrectinib) is an oral targeted therapy used to treat solid tumors with NTRK gene fusions, blocking TRK proteins to inhibit tumor growth and spread across various cancers.
#Laronib100mg #Larotrectinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/laro...

Ibruxen 140 mg (Ibrutinib) | Online International Pharmacy Ibruxen 140 mg (Ibrutinib) is a targeted therapy used to treat certain blood cancers by inhibiting Bruton's tyrosine kinase.

Ibruxen 140 mg (Ibrutinib) is an oral medication used to treat blood cancers like chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenström’s by inhibiting Bruton's tyrosine kinase (BTK).
#Ibruxen140mg #Ibrutinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/ibru...

Gilternib 40 mg (Gilteritinib) | Online International Pharmacy Gilternib 40 mg (Gilteritinib) is used to treat relapsed or refractory acute myeloid leukemia with FLT3 mutation, targeting cancer cell growth.

Gilternib 40 mg (Gilteritinib) is an oral targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with FLT3 mutations, inhibiting FLT3 to slow cancer cell growth and spread.
#Gilternib40mg #Gilteritinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/gilt...

Elopag 50 mg (Eltrombopag) | Online International Pharmacy Elopag 50 mg (Eltrombopag) is used to treat low platelet levels in chronic ITP or hepatitis C-related thrombocytopenia, improving clotting function.

Elopag 50 mg (Eltrombopag) is an oral medication used to treat low platelet counts in conditions like chronic immune, aplastic anemia, and hepatitis C-related thrombocytopenia by stimulating platelet production.
#Elopag50mg #Eltrombopag #OnlineMedicine #Oncology #Health
jnspharma.com/product/elop...

Erdafixen 4 mg (Erdafitinib) | Online International Pharmacy Erdafixen 4 mg (Erdafitinib) is a targeted cancer therapy used to treat urothelial carcinoma with specific FGFR genetic alterations in adults.

Erdafixen 4 mg (Erdafitinib) is a targeted cancer therapy used for advanced bladder cancer with FGFR2/FGFR3 alterations, blocking fibroblast growth factor inhibit tumor growth and improve treatment outcomes.
#Erdafixen4mg #Erdafitinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/erda...

Daconib 45 mg (Dacomitinib) | Online International Pharmacy Daconib 45 mg (Dacomitinib) is a targeted therapy used to treat non-small cell lung cancer with specific EGFR gene mutations.

Daconib 45 mg (Dacomitinib) is an oral tyrosine kinase inhibitor used for the treatment of metastatic non-small cell lung cancer (NSCLC) with EGFR gene mutations, helping block cancer cell growth and spread.
#Daconib45mg #Dacomitinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/daco...

Caboxen 20 Mg (Cabozantinib) | Online International Pharmacy Caboxen 20 mg (Cabozantinib) is used to treat advanced kidney, liver, and thyroid cancers by inhibiting tumor growth and angiogenesis.

Caboxen 20 mg (Cabozantinib) is a tyrosine kinase inhibitor used to treat cancers like renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer by blocking tumor growth and angiogenesis pathways.
#Caboxen20Mg #Cabozantinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/cabo...

Alpesib 150 mg (Alpelisib) | Online International Pharmacy Alpesib 150 mg (Alpelisib) is used to treat advanced breast cancer by inhibiting PI3K, a key cancer cell growth signaling pathway.

Alpesib 150 mg (Alpelisib) is a targeted therapy used in combination with other treatments for advanced breast cancer, specifically in patients with PIK3CA mutations, by inhibiting the PI3K pathway.
#Alpesib150mg #Alpelisib #OnlineMedicine #Oncology #Health
jnspharma.com/product/alpe...

Azarest 300 mg (Azactidine) | Online International Pharmacy Azarest 300 mg (Azacitidine) is a chemotherapy medicine used to treat myelodysplastic syndromes and certain types of leukemia in adults.

Azarest 300 mg (Azacitidine) is a chemotherapy drug used to treat myelodysplastic syndromes and acute myeloid leukemia by restoring normal blood cell production and slowing abnormal cell growth.
#Azarest300mg #Azactidine #OnlineMedicine #Oncology #Health
jnspharma.com/product/azar...

Alkixen 250 mg (Crizotinib) | Online International Pharmacy Alkixen 250 mg (Crizotinib) is used to treat ALK-positive non-small cell lung cancer by inhibiting abnormal cancer cell growth.

Alkixen 250 mg (Crizotinib) is an oral medication used to treat non-small cell lung cancer (NSCLC) with ALK or ROS1 gene mutations, helping slow cancer growth and spread.
#Alkixen250mg #Crizotinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/alki...

Acaluxen 100 mg (Acalabrutinib) | Online International Pharmacy Acaluxen 100 mg (Acalabrutinib) is a Bruton tyrosine kinase inhibitor used to treat certain blood cancers like CLL and mantle cell lymphoma.

Acaluxen 100 mg (Acalabrutinib) is a targeted therapy used to treat certain blood cancers like mantle cell lymphoma and chronic lymphocytic leukemia by inhibiting Bruton's tyrosine kinase (BTK).
#Acaluxen100mg #Acalabrutinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/acal...

JNS Pharma provides innovative cancer medicines with dedicated patient support, ensuring accessibility, affordability, compassionate care, and improved treatment outcomes worldwide.
#Jnspharma #cancer #medicines #oncologymedicine #lungcancer #kidneycancer #breastcancer
jnspharma.com